Drug screening of food and drug administration-approved compounds against Babesia bovis in vitro

Y Li, M Liu, MA Rizk, PFA Moumouni, SH Lee… - Experimental …, 2020 - Elsevier
Babesia (B.) bovis is one of the main etiological agents of bovine babesiosis, causes serious
economic losses to the cattle industry. Control of bovine babesiosis has been hindered by …

Discovering the Potent Inhibitors Against Babesia bovis in vitro and Babesia microti in vivo by Repurposing the Natural Product Compounds

Y Li, MA Rizk, EM Galon, M Liu, J Li… - Frontiers in Veterinary …, 2021 - frontiersin.org
In the present study, we screened 502 natural product compounds against the in vitro growth
of Babesia (B.) bovis. Then, the novel and potent identified compounds were further …

Comparative efficacy of buparvaquone and imidocarb in inhibiting the in vitro growth of Babesia bovis

NM Cardillo, PA Lacy, NF Villarino… - Frontiers in …, 2024 - frontiersin.org
Introduction: B. bovis is an apicomplexan parasite responsible for bovine babesiosis, a tick-
borne disease with a worldwide impact. The disease remains inefficiently controlled, and …

[HTML][HTML] The Combination of Buparvaquone and ELQ316 Exhibit a Stronger Effect than ELQ316 and Imidocarb Against Babesia bovis In Vitro

NM Cardillo, NF Villarino, PA Lacy, MK Riscoe… - Pharmaceutics, 2024 - mdpi.com
Background/Objectives: Bovine babesiosis is a vector-borne disease transmitted by ticks
that causes important losses in livestock worldwide. Recent research performed on the …

In vitro screening of novel anti-Babesia gibsoni drugs from natural products

S Ji, M Liu, EM Galon, MA Rizk, J Li, Y Li, I Zafar… - Parasitology …, 2021 - Elsevier
Babesia gibsoni is a tick-transmitted intraerythrocytic apicomplexan parasite that causes
babesiosis in dogs. Due to the strong side effects and lack of efficacy of current drugs, novel …

Discovering the in vitro potent inhibitors against Babesia and Theileria parasites by repurposing the Malaria Box: A review

MA Rizk, SAES El-Sayed, S El-Khodery… - Veterinary …, 2019 - Elsevier
There is an innovative approach to discovering and developing novel potent and safe anti-
Babesia and anti-Theileria agents for the control of animal piroplasmosis. Large-scale …

In vitro screening of compounds from the Food and Drug Administration-approved library identifies anti-Babesia gibsoni activity of idarubicin hydrochloride and …

H Li, EM Galon, S Ji, I Zafar, Z Ma, T Do, MM Amer… - Parasitology …, 2023 - Elsevier
Babesia gibsoni is mainly transmitted by hard ticks of the genus Rhipicephalus (R.
sanguineus) and Haemaphysalis (H. longicornis), and causes canine babesiosis. Clinical …

Inhibitory effects on bovine babesial infection by iron chelator, 1-(N-acetyl-6-aminohexyl)− 3-hydroxy-2-methylpyridin-4-one (CM1), and antimalarial drugs

P Koonyosying, S Srichairatanakool… - Veterinary …, 2023 - Elsevier
Background Babesiosis is an infectious disease caused by protozoa of the apicomplexan
phylum, genus Babesia. It is a malaria-like parasitic disease that can be transmitted via tick …

Optimization of a Fluorescence-Based Assay for Large-Scale Drug Screening against Babesia and Theileria Parasites

MA Rizk, SAES El-Sayed, MA Terkawi, MA Youssef… - PloS one, 2015 - journals.plos.org
A rapid and accurate assay for evaluating antibabesial drugs on a large scale is required for
the discovery of novel chemotherapeutic agents against Babesia parasites. In the current …

Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of Babesia divergens, a Blood-Borne Parasite of Veterinary and Zoonotic Importance

MA Rizk, SAES El-Sayed, MS Alkhoudary, KF Alsharif… - Molecules, 2021 - mdpi.com
Babesiosis is an infectious disease with an empty drug pipeline. A search inside chemical
libraries for novel potent antibabesial candidates may help fill such an empty drug pipeline …